Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab
Clinical trial NCT06796114 · RECRUITING
Trial details
- NCT number
- NCT06796114
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-25
- Primary completion
- 2027-06-25
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.